Keyphrases
Peru
100%
Electron Microscopy
61%
Peruvian
43%
Primary Ciliary Dyskinesia
34%
Latin American
34%
Pediatric Patients
34%
Pneumonia
34%
Pulmonary Actinomycosis
34%
Pleural Empyema
34%
Amoebic Liver Abscess
34%
Child Self-report
34%
Thoracic Actinomycosis
34%
Media Economics
34%
Economic Resources
34%
ABCA3
34%
Surfactant
34%
Congenital Pulmonary Malformation
34%
Pulmonary Surfactant Dysfunction
34%
Caribbean Countries
34%
SP-C
34%
Mycoplasma
34%
Encephalitis
34%
Acute Myositis
34%
COVID-19
34%
Azithromycin
31%
Lamellar Bodies
31%
Hydroxychloroquine
31%
Country Income Level
29%
Case Fatality Rate
27%
Pediatric Population
27%
Eosinophilic Bronchitis
23%
Functional Limitations
23%
Mycoplasma Pneumoniae (M. pneumoniae)
23%
Antibiotics
20%
Surfactant Dysfunction
20%
Genetic Studies
20%
Response to Treatment
20%
Respiratory Distress
20%
Blood Coagulation Tests
17%
Mucocutaneous Involvement
17%
Complete Blood Count
17%
Multisystemic
17%
Kidney Involvement
17%
Prior Exposure
17%
Thrombus
17%
Fistulization
17%
Lung Consolidation
17%
Gram-positive Bacteria
17%
Parenchymal Lesions
17%
Degree of Difficulty
17%
Medicine and Dentistry
Disease
75%
Electron Microscopy
69%
Pediatrics
66%
Pulmonary Surfactant
58%
Surfactant
46%
Primary Ciliary Dyskinesia
34%
Pediatrics Patient
34%
Amoebic Liver Abscess
34%
Encephalitis
34%
Pulmonary Actinomycosis
34%
Azithromycin
34%
Bronchiolitis Obliterans
34%
Pleural Empyema
34%
Hydroxychloroquine
34%
Actinomycosis
34%
Surfactant Protein C
34%
Lamellar Body
34%
Mycoplasma
34%
Myositis
34%
Serositis
34%
Shock (Circulatory)
34%
COVID-19
34%
Genetic Disorder
31%
Neonatal Infant
23%
Functional Limitation
23%
Mycoplasma Pneumonia
23%
Kawasaki Disease
23%
Pulse Rate
23%
Respiratory Distress
23%
Methylprednisolone
23%
Infection
23%
Artificial Respiration
23%
Antibiotics
20%
Blood Clotting Test
17%
Intensive Care
17%
Elevated Transaminases
17%
Adenoviridae
17%
Mosaicism
17%
Thrombus
17%
Wheeze
17%
Rare Lung Disease
17%
Guillain-Barré Syndrome
17%
Dermatosis
17%
Orphan Disorder
11%
Thoracic Wall
11%
Electrocardiogram
11%
Lower Limb
11%
Immunoglobulin M
11%
Chest Tube
11%
Deterioration
11%